A FUNCTIONAL ROLE FOR INTERLEUKIN (IL)-4-DRIVEN CYCLIC AMP ACCUMULATION IN HUMAN B LYMPHOCYTES

Interleukin-4 (IL-4) regulates the expression of the 55-kDa α-subunit (CD25) of the IL-2 receptor complex in human B lymphocytes. This report suggests that the cAMP/protein kinase A (PKA) component of the IL-4 receptor signalling programme in human tonsillar B cells has a functionally important role...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cytokine (Philadelphia, Pa.) Pa.), 2000-06, Vol.12 (6), p.731-736
Hauptverfasser: McKay, Catriona E, Hewitt, Ellen L, Ozanne, Bradford W, Cushley, William
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 736
container_issue 6
container_start_page 731
container_title Cytokine (Philadelphia, Pa.)
container_volume 12
creator McKay, Catriona E
Hewitt, Ellen L
Ozanne, Bradford W
Cushley, William
description Interleukin-4 (IL-4) regulates the expression of the 55-kDa α-subunit (CD25) of the IL-2 receptor complex in human B lymphocytes. This report suggests that the cAMP/protein kinase A (PKA) component of the IL-4 receptor signalling programme in human tonsillar B cells has a functionally important role in regulating expression of the CD25 gene by attenuating activity of a protein binding to a potent negative regulatory element (NRE) in the CD25 promoter; this effect can be mimicked by agents that elevate cAMP and blocked by inhibitors of PKA but not protein kinase C (PKC). In a B-cell line that fails to elevate cAMP, attenuate NRE-binding protein (NRE-BP) activity or express CD25 following IL-4 treatment, stimulation of cAMP accumulation by forskolin facilitates IL-4-mediated induction of both the endogenous gene and an exogenous reporter gene under the control of a minimal promoter/enhancer fragment of the CD25 gene.
doi_str_mv 10.1006/cyto.1999.0627
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71169338</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1043466699906270</els_id><sourcerecordid>71169338</sourcerecordid><originalsourceid>FETCH-LOGICAL-c340t-c921fcea47e4b4da1b06d1ca47269376a772eb2e391fa283adcc27eee2bacdc73</originalsourceid><addsrcrecordid>eNp1kDtv2zAURokiQV7N2rHgFDSDXL5KWqPCyLVQWgpcq4CXEhR1DSiwI1eUA_jfV4IzZMnES-B8H-49CH2hZEIJkd_9sW8nNI7jCZFMfUJXlMQyIoTxs3EWPBJSykt0HcIzISTmSl2gS0qmgqsf4gr9TfCszPUqK_LE4GVhUjwrljjLV-nSpOWvLMffMnMfiehxmf1Jc6zX2mQaJ4snnGhdLkqTjOEhgeflIsnxAzbrxdO80OtV-vszOt-4bYDbt_cGlbN0peeRKX5mOjGR54L0kY8Z3XhwQoGoRO1oRWRN_fBnclhZOqUYVAx4TDeOTbmrvWcKAFjlfO0Vv0F3p9591_47QOjtrgketlv3Au0hWEXpUMSnAzg5gb5rQ-hgY_dds3Pd0VJiR6N2NGpHo3Y0OgS-vjUfqh3U7_CTwgGYngAY7nttoLPBN_DioW468L2t2-aj7v9YCH19</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71169338</pqid></control><display><type>article</type><title>A FUNCTIONAL ROLE FOR INTERLEUKIN (IL)-4-DRIVEN CYCLIC AMP ACCUMULATION IN HUMAN B LYMPHOCYTES</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>McKay, Catriona E ; Hewitt, Ellen L ; Ozanne, Bradford W ; Cushley, William</creator><creatorcontrib>McKay, Catriona E ; Hewitt, Ellen L ; Ozanne, Bradford W ; Cushley, William</creatorcontrib><description>Interleukin-4 (IL-4) regulates the expression of the 55-kDa α-subunit (CD25) of the IL-2 receptor complex in human B lymphocytes. This report suggests that the cAMP/protein kinase A (PKA) component of the IL-4 receptor signalling programme in human tonsillar B cells has a functionally important role in regulating expression of the CD25 gene by attenuating activity of a protein binding to a potent negative regulatory element (NRE) in the CD25 promoter; this effect can be mimicked by agents that elevate cAMP and blocked by inhibitors of PKA but not protein kinase C (PKC). In a B-cell line that fails to elevate cAMP, attenuate NRE-binding protein (NRE-BP) activity or express CD25 following IL-4 treatment, stimulation of cAMP accumulation by forskolin facilitates IL-4-mediated induction of both the endogenous gene and an exogenous reporter gene under the control of a minimal promoter/enhancer fragment of the CD25 gene.</description><identifier>ISSN: 1043-4666</identifier><identifier>EISSN: 1096-0023</identifier><identifier>DOI: 10.1006/cyto.1999.0627</identifier><identifier>PMID: 10843754</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>B-Lymphocytes - drug effects ; B-Lymphocytes - physiology ; Cells, Cultured ; Colforsin - pharmacology ; Cyclic AMP - metabolism ; Cyclic AMP-Dependent Protein Kinases - metabolism ; Enzyme Inhibitors - pharmacology ; Gene Expression Regulation - drug effects ; Humans ; IL-4 receptor/CD25 expression/cAMP/human B Lymphocytes ; Interleukin-4 - pharmacology ; Isoquinolines - pharmacology ; Kinetics ; Palatine Tonsil - immunology ; Receptors, Interleukin-2 - genetics ; Receptors, Interleukin-4 - physiology ; Signal Transduction ; Sulfonamides</subject><ispartof>Cytokine (Philadelphia, Pa.), 2000-06, Vol.12 (6), p.731-736</ispartof><rights>2000 Academic Press</rights><rights>Copyright 2000 Academic Press.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c340t-c921fcea47e4b4da1b06d1ca47269376a772eb2e391fa283adcc27eee2bacdc73</citedby><cites>FETCH-LOGICAL-c340t-c921fcea47e4b4da1b06d1ca47269376a772eb2e391fa283adcc27eee2bacdc73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/cyto.1999.0627$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10843754$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McKay, Catriona E</creatorcontrib><creatorcontrib>Hewitt, Ellen L</creatorcontrib><creatorcontrib>Ozanne, Bradford W</creatorcontrib><creatorcontrib>Cushley, William</creatorcontrib><title>A FUNCTIONAL ROLE FOR INTERLEUKIN (IL)-4-DRIVEN CYCLIC AMP ACCUMULATION IN HUMAN B LYMPHOCYTES</title><title>Cytokine (Philadelphia, Pa.)</title><addtitle>Cytokine</addtitle><description>Interleukin-4 (IL-4) regulates the expression of the 55-kDa α-subunit (CD25) of the IL-2 receptor complex in human B lymphocytes. This report suggests that the cAMP/protein kinase A (PKA) component of the IL-4 receptor signalling programme in human tonsillar B cells has a functionally important role in regulating expression of the CD25 gene by attenuating activity of a protein binding to a potent negative regulatory element (NRE) in the CD25 promoter; this effect can be mimicked by agents that elevate cAMP and blocked by inhibitors of PKA but not protein kinase C (PKC). In a B-cell line that fails to elevate cAMP, attenuate NRE-binding protein (NRE-BP) activity or express CD25 following IL-4 treatment, stimulation of cAMP accumulation by forskolin facilitates IL-4-mediated induction of both the endogenous gene and an exogenous reporter gene under the control of a minimal promoter/enhancer fragment of the CD25 gene.</description><subject>B-Lymphocytes - drug effects</subject><subject>B-Lymphocytes - physiology</subject><subject>Cells, Cultured</subject><subject>Colforsin - pharmacology</subject><subject>Cyclic AMP - metabolism</subject><subject>Cyclic AMP-Dependent Protein Kinases - metabolism</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Humans</subject><subject>IL-4 receptor/CD25 expression/cAMP/human B Lymphocytes</subject><subject>Interleukin-4 - pharmacology</subject><subject>Isoquinolines - pharmacology</subject><subject>Kinetics</subject><subject>Palatine Tonsil - immunology</subject><subject>Receptors, Interleukin-2 - genetics</subject><subject>Receptors, Interleukin-4 - physiology</subject><subject>Signal Transduction</subject><subject>Sulfonamides</subject><issn>1043-4666</issn><issn>1096-0023</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kDtv2zAURokiQV7N2rHgFDSDXL5KWqPCyLVQWgpcq4CXEhR1DSiwI1eUA_jfV4IzZMnES-B8H-49CH2hZEIJkd_9sW8nNI7jCZFMfUJXlMQyIoTxs3EWPBJSykt0HcIzISTmSl2gS0qmgqsf4gr9TfCszPUqK_LE4GVhUjwrljjLV-nSpOWvLMffMnMfiehxmf1Jc6zX2mQaJ4snnGhdLkqTjOEhgeflIsnxAzbrxdO80OtV-vszOt-4bYDbt_cGlbN0peeRKX5mOjGR54L0kY8Z3XhwQoGoRO1oRWRN_fBnclhZOqUYVAx4TDeOTbmrvWcKAFjlfO0Vv0F3p9591_47QOjtrgketlv3Au0hWEXpUMSnAzg5gb5rQ-hgY_dds3Pd0VJiR6N2NGpHo3Y0OgS-vjUfqh3U7_CTwgGYngAY7nttoLPBN_DioW468L2t2-aj7v9YCH19</recordid><startdate>20000601</startdate><enddate>20000601</enddate><creator>McKay, Catriona E</creator><creator>Hewitt, Ellen L</creator><creator>Ozanne, Bradford W</creator><creator>Cushley, William</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20000601</creationdate><title>A FUNCTIONAL ROLE FOR INTERLEUKIN (IL)-4-DRIVEN CYCLIC AMP ACCUMULATION IN HUMAN B LYMPHOCYTES</title><author>McKay, Catriona E ; Hewitt, Ellen L ; Ozanne, Bradford W ; Cushley, William</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c340t-c921fcea47e4b4da1b06d1ca47269376a772eb2e391fa283adcc27eee2bacdc73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>B-Lymphocytes - drug effects</topic><topic>B-Lymphocytes - physiology</topic><topic>Cells, Cultured</topic><topic>Colforsin - pharmacology</topic><topic>Cyclic AMP - metabolism</topic><topic>Cyclic AMP-Dependent Protein Kinases - metabolism</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Humans</topic><topic>IL-4 receptor/CD25 expression/cAMP/human B Lymphocytes</topic><topic>Interleukin-4 - pharmacology</topic><topic>Isoquinolines - pharmacology</topic><topic>Kinetics</topic><topic>Palatine Tonsil - immunology</topic><topic>Receptors, Interleukin-2 - genetics</topic><topic>Receptors, Interleukin-4 - physiology</topic><topic>Signal Transduction</topic><topic>Sulfonamides</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McKay, Catriona E</creatorcontrib><creatorcontrib>Hewitt, Ellen L</creatorcontrib><creatorcontrib>Ozanne, Bradford W</creatorcontrib><creatorcontrib>Cushley, William</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cytokine (Philadelphia, Pa.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McKay, Catriona E</au><au>Hewitt, Ellen L</au><au>Ozanne, Bradford W</au><au>Cushley, William</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A FUNCTIONAL ROLE FOR INTERLEUKIN (IL)-4-DRIVEN CYCLIC AMP ACCUMULATION IN HUMAN B LYMPHOCYTES</atitle><jtitle>Cytokine (Philadelphia, Pa.)</jtitle><addtitle>Cytokine</addtitle><date>2000-06-01</date><risdate>2000</risdate><volume>12</volume><issue>6</issue><spage>731</spage><epage>736</epage><pages>731-736</pages><issn>1043-4666</issn><eissn>1096-0023</eissn><abstract>Interleukin-4 (IL-4) regulates the expression of the 55-kDa α-subunit (CD25) of the IL-2 receptor complex in human B lymphocytes. This report suggests that the cAMP/protein kinase A (PKA) component of the IL-4 receptor signalling programme in human tonsillar B cells has a functionally important role in regulating expression of the CD25 gene by attenuating activity of a protein binding to a potent negative regulatory element (NRE) in the CD25 promoter; this effect can be mimicked by agents that elevate cAMP and blocked by inhibitors of PKA but not protein kinase C (PKC). In a B-cell line that fails to elevate cAMP, attenuate NRE-binding protein (NRE-BP) activity or express CD25 following IL-4 treatment, stimulation of cAMP accumulation by forskolin facilitates IL-4-mediated induction of both the endogenous gene and an exogenous reporter gene under the control of a minimal promoter/enhancer fragment of the CD25 gene.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>10843754</pmid><doi>10.1006/cyto.1999.0627</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1043-4666
ispartof Cytokine (Philadelphia, Pa.), 2000-06, Vol.12 (6), p.731-736
issn 1043-4666
1096-0023
language eng
recordid cdi_proquest_miscellaneous_71169338
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects B-Lymphocytes - drug effects
B-Lymphocytes - physiology
Cells, Cultured
Colforsin - pharmacology
Cyclic AMP - metabolism
Cyclic AMP-Dependent Protein Kinases - metabolism
Enzyme Inhibitors - pharmacology
Gene Expression Regulation - drug effects
Humans
IL-4 receptor/CD25 expression/cAMP/human B Lymphocytes
Interleukin-4 - pharmacology
Isoquinolines - pharmacology
Kinetics
Palatine Tonsil - immunology
Receptors, Interleukin-2 - genetics
Receptors, Interleukin-4 - physiology
Signal Transduction
Sulfonamides
title A FUNCTIONAL ROLE FOR INTERLEUKIN (IL)-4-DRIVEN CYCLIC AMP ACCUMULATION IN HUMAN B LYMPHOCYTES
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T23%3A04%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20FUNCTIONAL%20ROLE%20FOR%20INTERLEUKIN%20(IL)-4-DRIVEN%20CYCLIC%20AMP%20ACCUMULATION%20IN%20HUMAN%20B%20LYMPHOCYTES&rft.jtitle=Cytokine%20(Philadelphia,%20Pa.)&rft.au=McKay,%20Catriona%20E&rft.date=2000-06-01&rft.volume=12&rft.issue=6&rft.spage=731&rft.epage=736&rft.pages=731-736&rft.issn=1043-4666&rft.eissn=1096-0023&rft_id=info:doi/10.1006/cyto.1999.0627&rft_dat=%3Cproquest_cross%3E71169338%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71169338&rft_id=info:pmid/10843754&rft_els_id=S1043466699906270&rfr_iscdi=true